GlassScriptPhysician profile
Domenic C Izzo
NPI 1225028624
$1,715.75
in general payments reported to CMS, 2019-2025
19 companies · $179 in 2025
The $179 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $187 · 2020: $50.66 · 2021: $307 · 2022: $608 · 2023: $298 · 2024: $85.95 · 2025: $179.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $563.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $562.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $617.67 | 2019-2025 | Clareon, Clareon Panoptix Pro, Hydrus Microstent |
| Abbvie INC. | $250.58 | 2022-2025 | |
| Eyevance Pharmaceuticals LLC | $131.79 | 2022 | |
| Kala Pharmaceuticals, INC. | $124.57 | 2021-2022 | |
| Johnson & Johnson Surgical Vision, INC. | $115.54 | 2019-2022 | |
| Glaukos Corporation | $80.82 | 2022-2025 | Idosetr |
| Sight Sciences, INC. | $65.27 | 2022 | |
| Oyster Point Pharma, INC. | $62.37 | 2022-2023 | Tyrvaya |
| Allergan, INC. | $60.09 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $47.50 | 2023 | Eylea, Eylea Hd |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $29.38 | 2020-2021 | |
| Sun Pharmaceutical Industries INC. | $27.30 | 2021 | |
| Apellis Pharmaceuticals, INC. | $19.38 | 2023 | Syfovre |
| Shire North American Group INC | $18.92 | 2019 | |
| Biotissue Holdings INC. | $18.27 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dompe US, INC. | $12.60 | 2022 | |
| New World Medical,INC. | $12.56 | 2023 | |
| Novartis Pharmaceuticals Corporation | $11.16 | 2019 | |
| Quidel Corporation | $9.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Domenic Izzo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.